Cargando…
364 Zero Itch in Eyes Treated With Olopatadine Hydrochloride Ophthalmic Solution, 0.2% in Bilateral Conjunctival Allergen Challenge Studies
PURPOSE: To further assess the prevention of ocular itching with olopatadine hydrochloride ophthalmic solution, 0.2% (OLO) in patients with allergic conjunctivitis. METHODS: This was a post-hoc analysis of 85 patients participating in 2 prospective, randomized, double-masked bilateral conjunctival a...
Autores principales: | Blaiss, Michael S., Tort, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization Journal
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512759/ http://dx.doi.org/10.1097/01.WOX.0000412127.79639.64 |
Ejemplares similares
-
2 Dose Optimizing Study of a Depigmented Polymerized Allergen Extract of Birch Pollen by Means of Conjunctival Provocation Test
por: Sager, Angelika, et al.
Publicado: (2012) -
55 Ocular Signs and Symptoms Elicited by a Naturalistic Allergen Challenge in an Environmental Exposure Chamber Model Versus a Direct Allergen Instillation Model
por: Tort, Maria J., et al.
Publicado: (2012) -
369 Comparison of Skin and Conjunctival Reactivity to Aeroallergens
por: Mercer Mourão, Elizabeth Maria, et al.
Publicado: (2012) -
484 Allergen Standardisation in Allergens and Allergoids—Challenges and Considerations
por: Skinner, Murray, et al.
Publicado: (2012) -
170 Combination of a Nasal Antihistamine Olopatadine and A Leukotriene Receptor Antagonist Montelukast Sodium for the Treatment of Seasonal Allergic Patients not Currently Controlled on Monotherapy Intranasal Antihistamine or a Leukotriene Receptor Antagonist
por: Nsouli, Safa
Publicado: (2012)